INSIGHTS ON CLINICAL TRIAL PARTNERING

• Korio RTSM Platform: Site User Experience

  With minimal navigation, users of this platform can view a participant list, demographics, and status indicators — taking key actions like screening or randomizing without leaving the main grid.

• The Future Of Patient Experience: Lessons From GLP-1 Studies

  Improve adherence, retention, and data quality in GLP-1 and cardiometabolic trials through connected digital tools, real-time symptom tracking, caregiver support, and AI-assisted review.

• Q&A Workflow Automation To Financial Automation: The Next Step In Scalable Trials

  Workflow automation is only part of the solution. Integrating payments, travel, and forecasting with clinical operations supports more efficient trial execution.

• Breaking Down Operational And Financial Complexity In Clinical Trials

  Consider how factors like hybrid visits, enrollment patterns, and variable procedure volumes shape both the cadence and magnitude of site payments, supplier activity, and patient-related expenses.

• Accelerating Drug Development Through Integrated CDMO And CRO Partnership

  8/12/2026

  Coordinating drug substance, analytics, and clinical ops across multiple vendors puts you in the integrator role. See how connected CDMO-CRO partnerships eliminate that burden and reduce downstream risk.

• Unlocking Recruitment Potential In Trial-Naïve Sites

  4/17/2025

  Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

• Navigating The New Landscape Of Oncology Clinical Trials: A Strategic Imperative For Operations Teams

  6/18/2026

  The oncology landscape is growing but faces high screen-fail rates and trial complexity. To succeed, teams must move past traditional playbooks and adopt centralized pre-screening pipelines.

• 5 Questions That Put Sponsors Back in Control of Bioanalysis Projects

  12/9/2025

  Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims; demand better technology, pricing transparency, and dedicated partnership.

• Early-Stage Biotech's AI Advantage Is A Window That Closes

  5/6/2026

  The "greenfield" advantage allows biotechs to build AI-native trials from the start, replacing manual data entry with automated workflows and structured human oversight for better data integrity.